Chang Cory L, Sim Justin L, Delgardo Mychael W, Ruan Diana T, Connolly E Sander
Cerebrovascular Research Laboratory, Department of Neurological Surgery, Columbia University Irving Medical Center, New York, NY, United States.
Front Neurol. 2020 Jul 14;11:677. doi: 10.3389/fneur.2020.00677. eCollection 2020.
Growing evidence suggests that chronic subdural hematoma (CSDH) may have long-term adverse effects even after surgical evacuation. Hematoma recurrence is commonly reported as a short-term, postoperative outcome measure for CSDH, but other measures such as hematoma resolution may provide better insight regarding mechanisms behind longer-term sequelae. This study aims to characterize postoperative resolution times and identify predictors for this relatively unexplored metric. Consecutive cases ( = 122) of burr hole evacuation for CSDH by a single neurosurgeon at Columbia University Irving Medical Center from 2000 to 2019 were retrospectively identified. Patient characteristics, presenting factors, and date of hematoma resolution were abstracted from the electronic health record. Outcome measures included CSDH resolution at 6 months, surgery-to-resolution time, and inpatient mortality. Univariate and multivariate analyses were performed to determine predictors of outcome measures. Hematoma resolution at 6 months was observed in 58 patients (47.5%), and median surgery-to-resolution time was 161 days (IQR: 85-367). Heavy drinking was predictive of non-resolution at 6 months and longer surgery-to-resolution time, while increased age was predictive of non-resolution at 6 months. Antiplatelet agent resumption was associated with non-resolution at 6 months and longer surgery-to-resolution time on univariate analysis but was not significant on multivariate analysis. Postoperative resolution times for most CSDHs are on the order of several months to a year, and delayed resolution is linked to heavy drinking and advanced age. Subsequent prospective studies are needed to directly assess the utility of hematoma resolution as a potential metric for long-term functional and cognitive outcomes of CSDH.
越来越多的证据表明,慢性硬膜下血肿(CSDH)即使在手术清除后也可能产生长期不良影响。血肿复发通常被报告为CSDH的短期术后结局指标,但其他指标,如血肿消退情况,可能能更好地洞察长期后遗症背后的机制。本研究旨在描述术后消退时间特征,并确定这一相对未被充分探索指标的预测因素。回顾性确定了2000年至2019年在哥伦比亚大学欧文医学中心由一名神经外科医生进行钻孔引流治疗CSDH的连续病例(n = 122)。从电子健康记录中提取患者特征、就诊因素和血肿消退日期。结局指标包括6个月时CSDH消退情况、手术至消退时间和住院死亡率。进行单因素和多因素分析以确定结局指标的预测因素。58例患者(47.5%)在6个月时观察到血肿消退,手术至消退时间的中位数为161天(IQR:85 - 367)。大量饮酒可预测6个月时血肿未消退及手术至消退时间延长,而年龄增加可预测6个月时血肿未消退。单因素分析显示,恢复使用抗血小板药物与6个月时血肿未消退及手术至消退时间延长有关,但多因素分析中无显著意义。大多数CSDH的术后消退时间为几个月至一年,消退延迟与大量饮酒和高龄有关。后续需要进行前瞻性研究,以直接评估血肿消退作为CSDH长期功能和认知结局潜在指标的效用。